LPL Financial »

Alnylam Pharmaceuticals shares owned by LPL Financial

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by LPL Financial from 13F filings

Historical chart of LPL Financial investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by LPL Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by LPL Financial

Quarter filed Position value Share count Share price at filing
2012-09-30 $546k 29k 18.78

More positions owned by LPL Financial

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Vanguard Index Fds Total Stk Mkt (VTI)
Spdr Series Trust Prtflo S&p500 Gw (SPYG)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Spdr Series Trust Portfolio S&p500 (SPLG)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Amazon (AMZN)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Core Msci Emkt (IEMG)
Vanguard Index Fds Growth Etf (VUG)

View all positions for LPL Financial

Top funds holding Alnylam Pharmaceuticals

FMR
Capital World Investors
Vanguard Group
BlackRock
Capital Research Global Investors
Jpmorgan Chase & Co
Groupama Asset Managment
State Street Corporation
Baillie Gifford & Co
Geode Capital Management
Dodge & Cox
T. Rowe Price Investment Management
Orbis Allan Gray
Wellington Management Company
Susquehanna International

View all funds holding Alnylam Pharmaceuticals